StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note released on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Price Performance
ATHX opened at $0.00 on Monday. The firm has a market cap of $203,672.70, a P/E ratio of 0.00 and a beta of -0.90. Athersys has a twelve month low of $0.01 and a twelve month high of $1.99.
About Athersys
Want More Great Investing Ideas?
See Also
- Five stocks we like better than Athersys
- Stock Sentiment Analysis: How it Works
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- How to Start Investing in Real Estate
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.